-
1دورية أكاديمية
المؤلفون: Marco Stellato, Daniele Santini, Elena Verzoni, Ugo De Giorgi, Francesco Pantano, Chiara Casadei, Giuseppe Fornarini, Marco Maruzzo, Andrea Sbrana, Giuseppe Di Lorenzo, Mariella Soraru, Emanuele Naglieri, Sebastiano Buti, Rocco De Vivo, Andrea Napolitano, Francesca Vignani, Claudia Mucciarini, Francesco Grillone, Giandomenico Roviello, Marilena Di Napoli, Giuseppe Procopio
المصدر: Frontiers in Oncology, Vol 11 (2021)
مصطلحات موضوعية: nephrectomy, immune-oncology, metastatic renal cell carcinoma, immunotherapy, nivolumab, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2021.682449/fullTest; https://doaj.org/toc/2234-943XTest
-
2دورية أكاديمية
المؤلفون: Matteo Santoni, Sebastiano Buti, Zin W Myint, Marco Maruzzo, Roberto Iacovelli, Martin Pichler, Jindrich Kopecky, Jakub Kucharz, Mimma Rizzo, Luca Galli, Thomas Büttner, Ugo De Giorgi, Ravindran Kanesvaran, Ondřej Fiala, Enrique Grande, Paolo Andrea Zucali, Ray Manneh Kopp 17, Giuseppe Fornarini, Maria T Bourlon, Sarah Scagliarini, Javier Molina-Cerrillo, Gaetano Aurilio, Marc R Matrana, Renate Pichler, Carlo Cattrini, Tomas Büchler, Francesco Massari, Emmanuel Seront, Fabio Calabrò, Alvaro Pinto, Rossana Berardi, Anca Zgura, Giulia Mammone, Jawaher Ansari, Francesco Atzori, Rita Chiari, Aristotelis Bamias, Orazio Caffo, Giuseppe Procopio, Kaisa Sunela, Maria Bassanelli, Cinzia Ortega, Francesco Grillone, Johannes Landmesser, Michele Milella, Carlo Messina, Zsófia Küronya, Alessandra Mosca, Dipen Bhuva, Daniele Santini, Nuno Vau, Franco Morelli, Lorena Incorvaia, Sara Elena Rebuzzi, Giandomenico Roviello, Andrey Soares, Renato Bisonni, Davide Bimbatti, Ignacio Ortego Zabalza, Alessandro Rizzo, Veronica Mollica, Giulia Sorgentoni, Fernando Sabino M Monteiro, Nicola Battelli, Sergio Bracarda, Camillo Porta
المساهمون: Santoni, Matteo, Buti, Sebastiano, W Myint, Zin, Maruzzo, Marco, Iacovelli, Roberto, Pichler, Martin, Kopecky, Jindrich, Kucharz, Jakub, Rizzo, Mimma, Galli, Luca, Büttner, Thoma, De Giorgi, Ugo, Kanesvaran, Ravindran, Fiala, Ondřej, Grande, Enrique, Andrea Zucali, Paolo, Manneh Kopp 17, Ray, Fornarini, Giuseppe, T Bourlon, Maria, Scagliarini, Sarah, Molina-Cerrillo, Javier, Aurilio, Gaetano, R Matrana, Marc, Pichler, Renate, Cattrini, Carlo, Büchler, Toma, Massari, Francesco, Seront, Emmanuel, Calabrò, Fabio, Pinto, Alvaro, Berardi, Rossana, Zgura, Anca, Mammone, Giulia, Ansari, Jawaher, Atzori, Francesco, Chiari, Rita, Bamias, Aristoteli, Caffo, Orazio, Procopio, Giuseppe, Sunela, Kaisa, Bassanelli, Maria, Ortega, Cinzia, Grillone, Francesco, Landmesser, Johanne, Milella, Michele, Messina, Carlo, Küronya, Zsófia, Mosca, Alessandra, Bhuva, Dipen, Santini, Daniele, Vau, Nuno, Morelli, Franco, Incorvaia, Lorena, Elena Rebuzzi, Sara, Roviello, Giandomenico, Soares, Andrey, Bisonni, Renato, Bimbatti, Davide, Ortego Zabalza, Ignacio, Rizzo, Alessandro, Mollica, Veronica, Sorgentoni, Giulia, M Monteiro, Fernando Sabino, Battelli, Nicola, Bracarda, Sergio, Porta, Camillo
مصطلحات موضوعية: Keywords: ARON-1 study, Immune-oncology combination, Immunotherapy, Intermediate-risk International Metastatic Renal Cell Carcinoma Database Consortium criteria, NCT05287464, Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium criteria, Renal cell carcinoma, Survival
العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:001171176000001; journal:EUROPEAN UROLOGY ONCOLOGY; https://hdl.handle.net/11586/467980Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85184074251
-
3
المؤلفون: Francesca Vignani, Elena Verzoni, Mariella Sorarù, Francesco Grillone, Giandomenico Roviello, Rocco De Vivo, Giuseppe Di Lorenzo, Emanuele Naglieri, Sebastiano Buti, Marilena Di Napoli, Andrea Sbrana, Marco Stellato, Marco Maruzzo, Giuseppe Procopio, Daniele Santini, Ugo De Giorgi, Francesco Pantano, Andrea Napolitano, Giuseppe Fornarini, Claudia Mucciarini, Chiara Casadei
المصدر: Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncologyمصطلحات موضوعية: Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Urology, immune-oncology, metastatic renal cell carcinoma, 03 medical and health sciences, 0302 clinical medicine, Renal cell carcinoma, medicine, Overall survival, nephrectomy, 030212 general & internal medicine, Progression-free survival, RC254-282, Original Research, nivolumab, immunotherapy, Proportional hazards model, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Nephrectomy, Log-rank test, Oncology, 030220 oncology & carcinogenesis, Metastatic renal carcinoma, Nivolumab, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c608790657cc401d8d938d17c0a46d4Test
https://www.frontiersin.org/articles/10.3389/fonc.2021.682449/fullTest -
4
المؤلفون: Francesco Grillone, Giuseppe Procopio, Andrea Sbrana, Delia De Lisi, Daniele Santini, Sandro Pignata, Francesca Vignani, Sebastiano Buti, Emanuele Naglieri, Laura Attademo, Marco Maruzzo, Marco Stellato, Rocco De Vivo, Melissa Bersanelli, Davide Bimbatti, Francesco Pantano, Elena Verzoni, Mariella Sorarù, Ugo De Giorgi, Giuseppe Fornarini, Claudia Mucciarini, Chiara Casadei, Giuseppe Di Lorenzo, Enrico Mini
المصدر: American journal of clinical oncology. 44(3)
مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Cabozantinib, Pyridines, Programmed Cell Death 1 Receptor, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Renal cell carcinoma, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Anilides, 030212 general & internal medicine, Progression-free survival, Everolimus, Adverse effect, Carcinoma, Renal Cell, Immune Checkpoint Inhibitors, Aged, Retrospective Studies, business.industry, Hazard ratio, Retrospective cohort study, Middle Aged, medicine.disease, cabozantinib, immune-oncology, immunotherapy, renal cell carcinoma, therapeutic sequence, Carcinoma, Renal Cell, Disease Progression, Female, Italy, Kidney Neoplasms, Nivolumab, Treatment Outcome, Confidence interval, Oncology, chemistry, 030220 oncology & carcinogenesis, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a347a85f9d38514807dad0da00368341Test
https://pubmed.ncbi.nlm.nih.gov/33617179Test -
5
المؤلفون: Marco Stellato (10820005), Daniele Santini (222870), Elena Verzoni (725945), Ugo De Giorgi (2605693), Francesco Pantano (222879), Chiara Casadei (9414533), Giuseppe Fornarini (4669495), Marco Maruzzo (9595306), Andrea Sbrana (8979197), Giuseppe Di Lorenzo (430771), Mariella Soraru (10939920), Emanuele Naglieri (62205), Sebastiano Buti (3797485), Rocco De Vivo (10939923), Andrea Napolitano (838994), Francesca Vignani (10820014), Claudia Mucciarini (9595330), Francesco Grillone (10939926), Giandomenico Roviello (7134809), Marilena Di Napoli (9595285), Giuseppe Procopio (503244)
مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, nephrectomy, immune-oncology, metastatic renal cell carcinoma, immunotherapy, nivolumab